Request Access →
BA

Baiyee-Ndang Agbor-Baiyee

Founder & CEO, Manyu Tech LLC
About

The Story Behind Nephpros.

Baiyee-Ndang Agbor-Baiyee is the founder of Manyu Tech LLC and creator of Nephpros — the complete kidney disease research platform. He holds a Bachelor of Science from Howard University and a Master of Science from Touro College of Osteopathic Medicine in New York. He is associated with the Laboratory of Epigenetic and Metabolic Research at Howard University. He built Nephpros from direct experience as a working nephrology researcher — solving problems he encountered firsthand in the lab. Nephpros is the platform he wished existed when he started his research career.

Company

Manyu Tech LLC.

The Company
Manyu Tech LLC
Nephpros is developed and maintained by Manyu Tech LLC, a technology company focused on building purpose-built research infrastructure for medicine’s most underserved disease areas. Headquartered in Columbia, Maryland.
Columbia, MD Founded 2026 Patent Pending
The Product
Nephpros — Volume 1.0
A complete kidney disease research operating system. No installation, no IT requirements, no compromise. Designed to put professional-grade tools in the hands of every nephrologist and kidney researcher on the planet — from a major academic medical center to a single-investigator lab in any setting worldwide.
Intellectual Property
Provisional Patent Filed
A provisional patent application covering the full Nephpros system — including the AI Research Assistant module and the Clinical Trial Matching Marketplace — was filed with the United States Patent and Trademark Office on April 8, 2026.
Education

Academic Background.

Bachelor of Science — BS
Howard University
Master of Science — MS
Touro College of Osteopathic Medicine, New York
Research

Peer-Reviewed Publications

Four published papers in nephrology and molecular biology.

01
Peer-Reviewed
DOAJ — Directory of Open Access Journals
View Paper
02
Peer-Reviewed
Journal of Clinical and Translational Science — Cambridge University Press
View Paper
04
Peer-Reviewed
PubMed Central — National Institutes of Health
View Paper
Research Institution

Howard University.

Founding Research Institution & Pilot Site
Laboratory of Epigenetic and Metabolic Research
The Laboratory of Epigenetic and Metabolic Research at Howard University is the founding research institution behind Nephpros — where the platform was conceived, developed, and validated against the real-world workflows of an active nephrology research lab.
Currently piloting: Nephpros is currently being piloted with nephrology research laboratories at Howard University.
Pilot Partner — Active Use
Vision

“Nephpros exists because kidney disease research deserves better tools. Every feature in this platform was built to solve a real problem I faced as a researcher. The goal is simple — give every nephrology lab in the world access to the kind of research infrastructure that used to require a team of data scientists and a six-figure software budget.”

Contact

Get in Touch.

nephpros.io@gmail.com

For research collaborations, pilot inquiries, or press.

Nephpros

See the Platform
He Built.

Kidney disease research, reimagined from the ground up.

Request Access Open App →